Adam Morgan

Iguana Healthcare Management Healthcare’s investment objective is for its clients to maximum returns from investing long and short globally in public companies in the life sciences industry while actively managing both sector and global risk with an eye on capital preservation. The broad base of investment opportunities includes, but is not limited to companies focusing on biotechnology, branded pharmaceuticals, generic pharmaceutics, medical devices and medical supplies, healthcare service providers, and healthcare information technology. Iguana Healthcare clients’ portfolios are constructed using a multi-factorial approach with a focus on balancing risk and liquidity with expected returns on individual stocks and with their impact on upon overall portfolio concentration. Portfolios are constructed stock-by-stock and not sub-sector by sub-sector.

Pura Vida employs a fundamentally driven investment approach that is focused on the healthcare sector. The firm uses a broad set of research tools in constructing its investment portfolios. They may, from time to time, make activist and/or control investments with respect to the issuer of an asset held in a client’s portfolio. Their investment strategies primarily involve trading equity and debt, both long and short, as well as derivatives of public and private issuers globally.

Functions as a College/University

Avego Healthcare invests in private and public companies located in the United States. The firm targets companies operating in the fields of specialty pharmaceuticals, pharma services, life sciences tools, over-the-counter products and medical devices & equipment sectors. It provides financing for buyout stage transactions.

Velan Capital manages a long/short investment strategy for their clients.

Provides health predictions using technology